By Editor Panel, Lifescience Outlook, Editor
New EHR tools and a health information network aim to simplify clinical workflows, connect patient data, and support smarter healthcare decisionsOrlando, 24 September 2026 – Healthcare organizations m...
By Editor Panel, Lifescience Outlook, Editor
Smarter data analysis, faster research, and growing investment are giving artificial intelligence a bigger role in the search for new medicinesBoston, Massachusetts, 15 September 2026 – Artificial int...
By Editor Panel, Lifescience Outlook, Editor
A new study shows how quantum computing could help AI create more useful drug candidates and explore possibilities beyond its training dataBurnaby, British Columbia, 25 August 2026 – Generative artifi...
By Editor Panel, Lifescience Outlook, Editor
Five late-stage drug candidates are drawing attention as researchers search for more effective, targeted, and convenient options for people living with ulcerative colitis.New York, 8 September 2026 –...
By Editor Panel, Lifescience Outlook, Editor
AI, investment, biotechnology and stronger regional partnerships are creating a new path for Asia Pacific healthcare companies to take their ideas from the laboratory to international marketsSingapore...
By Editor Panel, Editor, Lifescience Outlook
By Editor Panel, Editor, Lifescience Outlook
By Editor Panel, Editor, Lifescience Outlook
By Editor Panel, Editor, Lifescience Outlook
By Polly Astill, Marketing Campaign Manager, Sygnature Discovery
Biomarker discovery lies at the heart of the translational gap in drug development. Too often, programs stall, and compounds fail in late-stage trials. Retrospective analyses repeatedly point to the s...
By Daniel-Paul Bednarík, PhD, Chief Technology Officer, Black Canyon Bio, Inc.
Developing a new medicine is difficult. Scientists must understand a disease, identify a biological target, find a compound or biologic that modulates it, and show that it is safe and effective. Most...
By Michael N. Liebman, PhD, Managing Director, IPQ Analytics LLC
Approximately $10B is being invested globally in the development and application of AI in Drug Discovery in 2026. As a systems modeler, I see current investment focusing on dealing with the compl...
By Haider Alleg, General Partner, Allegory Capital
Most search queries today see no click through – artificial intelligence gives responses on the spot. Six out of ten times,users take what they need right there. Companies in life sciences notice this...
By Giulia Carna, Senior Data Protection Counsel, ACI Worldwide
AbstractOrganizations today operate in environments characterized by complex risk landscapes. Catastrophic events such as cyberattacks, natural disasters, pandemics and third-party failures pose...
